Lansen Pharmaceutical Holdings Limited (SEHK:503) will seek acquisitions. Lansen Pharmaceutical to issue 49.5 million placing shares at HKD 1.20/share. Net proceeds from subscriptions expected to be HKD 59.15 million and the Company intends to use net proceeds for potential future acquisitions, among others.
Lansen Pharmaceutical Holdings Limited
Equities
503
KYG5380M1033
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+26.67% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.77% | 231B | |
+5.24% | 200B | |
-8.79% | 195B | |
-6.26% | 145B |